EarlySight
Latest round
- Seed
Last raised
- Sep 2025
Total raised
- $6.4M
Investors
- 6
About EarlySight
Founded in 2019, EarlySight SA is located in Geneva, Switzerland, and focuses on developing an innovative ophthalmic camera. The founding team consists of Christophe Moser, Mathieu Kunzi, and Timothé Laforest, who serves as the CEO. EarlySight's core offering is its innovative ophthalmic camera, designed to provide high-resolution imaging of the retina at a cellular level. This advanced optical instrument utilizes disruptive infrared transscleral flood illumination combined with adaptive optics to deliver detailed images of retinal structures such as the retinal pigment epithelium (RPE), photoreceptors, and nerve fiber layers. The technology facilitates precise detection and monitoring of eye diseases, addressing significant unmet medical needs in the field of ophthalmology. By enabling healthcare professionals to observe individual cells impacted by diseases, EarlySight aims to enhance early diagnosis, track disease progression, and evaluate treatment effects.EarlySight generates revenue primarily through the sale of its flagship imaging device and associated software solutions to hospitals, clinics, and research institutions. The company engages in direct-to-consumer and B2B transactions, focusing on partnerships with eye care professionals. Its revenue structure includes one-time equipment sales along with ongoing service contracts for software updates and support. Additionally, as the AI software for analyzing images and detecting disease biomarkers is developed, it is anticipated to enhance the company’s revenue streams by offering subscription-based analytics services. The transaction model aims to create long-term relationships with healthcare providers, ensuring they have access to imaging technology and ongoing support as they monitor patients with retinal diseases.S. regulatory approval of the imaging device.
Who invested in EarlySight
6 investors across 2 rounds
See all investors in EarlySight
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about EarlySight
Who invested in EarlySight?
EarlySight has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has EarlySight raised?
EarlySight has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did EarlySight last raise money?
EarlySight's most recent round on record is a Seed, in Sep 2025.
What does EarlySight do?
Founded in 2019, EarlySight SA is located in Geneva, Switzerland, and focuses on developing an innovative ophthalmic camera.
Where is EarlySight headquartered?
EarlySight is headquartered in Geneva, Switzerland.
Which VCs invest in companies like EarlySight?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back medical devices & equipment companies at EarlySight's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Seed
Raising like EarlySight? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.